Welsis Corp. (WLSS) Financial Statements (2025 and earlier)

Company Profile

Business Address 701 E CATHEDRAL RD
PHILADELPHIA, PA 19128
State of Incorp. WY
Fiscal Year End September 30
Industry (SIC) 80 - Health Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
Q1
9/30/2024
Q4
6/30/2024
Q3
3/31/2024
Q2
12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
ASSETS
Current Assets
Prepaid expense      
Other undisclosed current assets    1105
Total current assets:   1105
Noncurrent Assets
Intangible assets, net (including goodwill)(15)1719212325
Goodwill (15)     
Intangible assets, net (excluding goodwill) 1719212325
Other undisclosed noncurrent assets      
Total noncurrent assets: (15)1719212325
TOTAL ASSETS:(15)1719233331
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:17107879181
Accounts payable    777674
Accrued liabilities1512109167
Other undisclosed accounts payable and accrued liabilities2(2)(3)   
Debt40     
Other undisclosed current liabilities151210272027
Total current liabilities:722218114111108
Noncurrent Liabilities
Long-term debt and lease obligation184040404040
Long-term debt, excluding current maturities184040404040
Other undisclosed noncurrent liabilities  11    
Total noncurrent liabilities:185140404040
Total liabilities:907358154151148
Equity
Equity, attributable to parent(90)(56)(38)(131)(118)(118)
Common stock000000
Additional paid in capital767676232323
Accumulated deficit(165)(131)(114)(154)(141)(140)
Other undisclosed equity    (0)  
Total equity:(90)(56)(38)(131)(118)(118)
TOTAL LIABILITIES AND EQUITY: 1719233331

Income Statement (P&L) ($ in thousands)

12/31/2024
Q1
9/30/2024
Q4
6/30/2024
Q3
3/31/2024
Q2
12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
Revenues    284
Gross profit:    284
Operating expenses(16)(16)(14)(15)(8)(8)
Operating loss:(16)(16)(14)(13)(0)(4)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(18)(2)54   
Interest and debt expense   55   
Net income (loss):(34)(17)95(13)(0)(4)
Other undisclosed net loss attributable to parent   (55)   
Net income (loss) available to common stockholders, diluted:(34)(17)40(13)(0)(4)

Comprehensive Income ($ in thousands)

12/31/2024
Q1
9/30/2024
Q4
6/30/2024
Q3
3/31/2024
Q2
12/31/2023
Q1
9/30/2023
Q4
6/30/2023
Q3
Net income (loss):(34)(17)95(13)(0)(4)
Comprehensive income (loss), net of tax, attributable to parent:(34)(17)95(13)(0)(4)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: